Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients

Exclusion Criteria

• •Pregnant or breast feeding mothers
• •Patients with conditions contraindicated for treatment
• •Patients with a history of clinically significant diseases
• •Patients who have a clinically significant renal disease
• •Patients with myocardial infarctions less than 6 months prior to study entry
• •Patients with recent (less than 1 year) history of NYHA Class III/IV left ventricular failure.
• •Patients with narrow-angle glaucoma, symptomatic prostatic hyperplasia or bladder-neck obstruction or urinary retention
• •Patients with a history of malignancy of any organ system
• •Patients who have had a COPD exacerbation that required treatment with antibiotics, and/or systemic steroids (oral or intravenous) and/or hospitalization in the 6 weeks prior to Screening
• •Patients who have had a respiratory tract infection within 6 weeks prior to Screening
• •Patients with any history of asthma.